Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Afrezza is an ultra-rapid-acting, inhaled human insulin used to manage mealtime blood sugar in adults and children with diabetes. It uses Technosphere® technology to deliver dry powder insulin via a portable oral inhaler for rapid lung absorption.
| Drug Class | Inhaled Insulin, Rapid-Acting Insulin, Technosphere Insulin |
| Indication Tags | Diabetes Mellitus (Type 1 and Type 2), Glycemic Control. |
| Dosage Strengths | 4-unit, 8-unit, and 12-unit , single-dose cartridges. |
| Delivery System | Oral inhaler device and single-use cartridges |
| Active Ingredient | Insulin human (recombinant DNA origin) |